Clinical Trials Logo
  1. Home
  2. Alzheimer Disease, Early Onset
  3. NCT06268886

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease — TargetTau-1  

Alzheimer Disease, Early Onset Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Global, Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants With Early Alzheimer's Disease (TargetTau-1)

Clinical Trial Summary

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06268886
Study type Interventional
Source Bristol-Myers Squibb
Contact BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Phone 855-907-3286
Email Clinical.Trials@bms.com
Status Recruiting
Phase Phase 2
Start date March 20, 2024
Completion date November 16, 2027
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03625401 - Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease Phase 2
Recruiting NCT05983575 - A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease Phase 3
Completed NCT05989087 - The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
Recruiting NCT06080659 - Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity N/A
Not yet recruiting NCT06099587 - MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease N/A
Not yet recruiting NCT05604183 - Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease N/A
Withdrawn NCT03514875 - Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients N/A
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Completed NCT03706885 - Efavirenz for Patients With Alzheimer's Disease Phase 1
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Not yet recruiting NCT05006599 - SNIFF - 3-Week Aptar CPS Device Phase 2
Recruiting NCT02740634 - Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study N/A
Active, not recruiting NCT03069391 - The Interactive Physical and Cognitive Exercise System N/A
Recruiting NCT04701957 - The Ketogenic Diet for Alzheimer's Disease N/A
Recruiting NCT04100889 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Recruiting NCT04656860 - Juice Plus Supplement Clinical Trial N/A
Recruiting NCT05315895 - The Dampness Syndrome of Chinese Medicine Cohort Study
Recruiting NCT04916964 - Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) N/A
Recruiting NCT04804618 - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
Recruiting NCT04680013 - Genetic Studies in Familial Dementia